v3.26.1
Consolidated balance sheets - EUR (€)
€ in Millions
Jun. 30, 2026
Dec. 31, 2025
Assets    
Property, plant and equipment owned € 10,364 € 10,052
Right-of-use assets 1,590 1,459
Goodwill 41,954 41,300
Other intangible assets 26,359 26,261
Investments accounted for using the equity method 3,207 3,259
Other non-current assets 4,732 4,364
Non-current income tax assets 569 550
Deferred tax assets 8,763 8,608
Non-current assets 97,538 95,853
Inventories 11,127 10,214
Accounts receivable 8,714 8,410
Other current assets 4,282 4,066
Current income tax assets 492 397
Cash and cash equivalents 6,350 7,657
Assets held for sale 557 208
Current assets 31,522 30,952
Total assets 129,060 126,805
Equity and liabilities    
Equity attributable to equity holders of Sanofi 69,207 71,376
Equity attributable to non-controlling interests 360 334
Total equity 69,567 71,710
Long-term debt 14,646 14,248
Non-current lease liabilities 1,677 1,467
Non-current liabilities related to business combinations and to non-controlling interests 652 585
Non-current provisions and other non-current liabilities 6,848 6,703
Non-current income tax liabilities 2,187 2,081
Deferred tax liabilities 1,553 1,666
Non-current liabilities 27,563 26,750
Accounts payable 7,150 7,361
Current liabilities related to business combinations and to non-controlling interests 0 0
Current provisions and other current liabilities 16,446 15,565
Current income tax liabilities 884 751
Current lease liabilities 227 272
Short-term debt and current portion of long-term debt 7,026 4,342
Liabilities related to assets held for sale 197 54
Current liabilities 31,930 28,345
Total equity and liabilities € 129,060 € 126,805